Data on intervention context, implementation and mechanisms used in meta-regression analysis
| Study author | Country and main year of implementation | National estimates of % PLHIV on ART | Total population in intervention area | HIVST distributed (total and per 1000 residents of intervention areas) | Reported HIVST use in previous 12 months at endline survey (%) | Know where to access care if test HIV-positive |
| Indravudh et al 17 | Malawi, 2017 | 72.6 | Total population: 93 640 adults; 44 390 in intervention area | Total: 220 314 (including intervention and other distribution areas). No population denominator available for HIVST distribution in this study | 37.7* | 74.7% |
| Indravudh et al 8 | Malawi, 2019 | 78.5 | Total population: 84 392 residents; 44 519 in intervention area | Total: 24 316 Per 1000 intervention population: 546 | 74.7† | Data not available |
| Neuman et al 18 | Zambia, 2017 | 72.2 | Total population: 308 822; 148 541 in intervention area | Total: 65 585 Per 1000 intervention population: 442 | 23.2* | 78.7% |
| Sibanda et al 13 | Zimbabwe, 2017 | 67.9 | Total population: 195 076 | Total: 80 378 Per 1000 intervention population: 412 | 50.2†* | 57.4% |
| Sibanda et al 16 | Zimbabwe, 2019 | 76.5 | Total population of HIVST wards: 242 096 | Total: 59 631 Per 1000 intervention population: 246 | 24.5†* | 76.7% |
*HIVST uptake ascertained after 12–16 months of continuous distribution.
†HIVST uptake ascertained 3 months after the start of campaign-style distribution.
‡HIVST update ascertained during campaign-style distribution.
ART, antiretroviral therapy; HIVST, HIV self-testing; PLHIV, people living with HIV.